Last subject In for a global clinical ph3b trial

In total 600 patients were randomized in 40 sites, 6 countries (EU).  This achievement fitted in the clinical development program (German pharmaceutical company) for which I, in the role as global clinical project leader, was responsible for the overall budget, timelines and program-management.